Tradestie Institutional Equity Comparison Engine
AQST vs HRMY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HRMY Overall Edge
HRMY Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Harmony Biosciences Holdings, Inc. Common Stock (HRMY) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AQST trades at N/M Forward P/E with -114.1% operating margin (-41.0% YoY revenue) versus HRMY at 5.4x Forward P/E and 22.2% operating margin (+12.3% YoY). In options structure, AQST sits in BREAKDOWN (64th %ile IV; Dealer Gamma Walls on Pro) against HRMY sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
HRMY
AQST N/M vs HRMY 5.4x Fwd P/E
Growth & Margin Winner
HRMY
Op Margin -114.1% vs 22.2% ยท YoY -41.0% vs +12.3%
Momentum & Technical Winner
HRMY
1Y -40.6% vs -2.2% ยท 52W Pos 14% vs 38%
Options & Structure Winner
HRMY
BREAKDOWN (64th %ile IV) vs CONSOLIDATION (11th %ile IV)
AQST
NASDAQ
Aquestive Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$3.46
-6.61% 1D
Market Cap
$465.7M
1M Return
-16.22%
1Y Return
-40.65%
Forward P/E
N/M
Unified AI Score
62.9 / 100
BUY
Tech 54.0
Fund 68.0
Flow 68.0
Mom 60.0
HRMY
NASDAQ
Harmony Biosciences Holdings, Inc. Common Stock
Pharmaceutical Preparations
$32.59
-1.18% 1D
Market Cap
$1.9B
1M Return
-9.55%
1Y Return
-2.16%
Forward P/E
5.4x
Unified AI Score
67.1 / 100
BUY
Tech 80.0
Fund 74.0
Flow 70.0
Mom 70.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AQST -40.65%
HRMY -2.16%
Spread: +38.49 pp (HRMY Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AQST Revenue | HRMY Revenue | AQST Op. Margin | HRMY Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $70M | N/A | -72.6% | N/A | AQST |
| FY2019 | $50M | $10M | -100.1% | -2433.8% | AQST |
| FY2020 | $50M | $160M | -93.6% | 10.6% | HRMY |
| FY2021 | $50M | $310M | -68.2% | 28.7% | HRMY |
| FY2022 | $50M | $440M | -88.2% | 27.4% | HRMY |
| FY2023 | $50M | $580M | -29.9% | 33.0% | HRMY |
| FY2024 | $60M | $710M | -53.5% | 26.7% | HRMY |
| FY2025 | $40M | $870M | -159.5% | 24.0% | HRMY |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AQST | HRMY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $465.7M | $1.9B | Larger Scale | HRMY |
| Trailing P/E Ratio Valuation | N/M | 10.9x | Lower Multiple | HRMY |
| Forward P/E Ratio Valuation | N/M | 5.4x | Lower Multiple | HRMY |
| Revenue Growth (YoY) Growth | -41.0% | +12.3% | Higher Growth | HRMY |
| Operating Margin (TTM) Profitability | -114.1% | 22.2% | Higher Margin | HRMY |
| Net Profit Margin Profitability | -162.3% | 18.1% | Higher Margin | HRMY |
| Return on Equity (ROE) Capital Efficiency | 0.0% | 18.7% | Higher ROE | HRMY |
| 52-Week Range Position Momentum | 14% ($3โ$7) | 38% ($26โ$43) | Stronger Trend | HRMY |
| Beta / 30D Volatility Risk Regime | 0.89ฮฒ ยท 56% Vol | 0.55ฮฒ ยท 38% Vol | Lower Realized Risk | HRMY |
| Unified Institutional Score Composite Signal | 62.9 / 100 (BUY) | 67.1 / 100 (BUY) | Higher Composite | HRMY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AQST vs HRMY Buy Guide
AQST
BREAKDOWN
61d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
64th %ile
IV Regime
Elevated (60thโ80th %ile)
HRMY
CONSOLIDATION
114d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
11th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AQST nor HRMY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.